Nektar Small Molecule PEGylation programs highlighted in the March 2008 issue of R&D Directions.
more
August 6, 2008Nektar Therapeutics Names Randall Moreadith, M.D., Ph.D. Senior Vice President, Drug Development and Chief Development Officer August 6, 2008Nektar Therapeutics Announces Second Quarter 2008 Results
August 6, 2008 Q2 2008 Nektar Therapeutics Financial Results Call Listen to Webcast
June 2, 2008 Presentation by Lead Clinical Investigator for NKTR-102 during ASCO 2008 Listen to Webcast
Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan) more
New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise of Nektar's Innovative Small Molecule PEG-Oncolytics more
Cimzia® approved in the U.S. for Crohn’s Disease more
Positive Phase 2 Data Presented for NKTR-061 at American Thoracic Society Meeting in Toronto more
Listen to Webcast
